Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 721

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

Open access
Glauser, Tracy, Ben‐Menachem, Elinor, Bourgeois, Blaise, Cnaan, Avital, Guerreiro, Carlos, Kälviäinen, Reetta, Mattson, Richard, French, Jacqueline A., Perucca, Emilio, Tomson, Torbjorn, for the ILAE Subcommission on AED Guidelines · 2013 · Epilepsia

Abstract

Summary: The purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long‐term efficacy or effectiveness for antiepileptic drugs (AED s) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from J uly 2005 until M arch 2012 were identified, evaluated, and combined with the previous analysis (Glauser et al., 2006) to provide a comprehensive update. The prior analysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were analyzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations. This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent‐to‐treat analysis. Since J uly, 2005, three class I randomized controlled trials (RCT) and 11 class III RCT s have been published. The combined analysis (1940–2012) now includes a total of 64 RCT s (7 with class I evidence, 2 with class II evidence) and 11 meta‐analyses. New efficacy/effectiveness findings include the following: levetiracetam and zonisamide have level A evidence in adults with partial onset seizures and both ethosuximide and valproic acid have level A evidence in children with childhood absence epilepsy. There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for adults with partial onset seizures. Although ethosuximide and valproic acid now have level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCT s for patients with generalized seizures/epilepsies and in children in general. These findings reinforce the need for multicenter, multinational efforts to design, conduct, and analyze future clinically relevant adequately designed RCT s. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/epi.12074

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 14

  1. Bourgeois B, 1998, Gabapentin(Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes(BECTS): a 36‐week, double‐blind, placebo‐controlled study, Epilepsia, 39, 163
  2. 10.1111/j.0013-9580.2004.40903.x · doi:10.1111/j.0013-9580.2004.40903.x
  3. 10.1016/j.seizure.2011.04.005 · doi:10.1016/j.seizure.2011.04.005
  4. 10.1212/01.wnl.0000210517.03902.6e · doi:10.1212/01.wnl.0000210517.03902.6e
  5. 10.1136/jnnp.45.12.1113 · doi:10.1136/jnnp.45.12.1113
  6. Loiseau P, 1984, [Efficacy of sodium valproate in partial epilepsy. Crossed study of valproate and carbamazepine], Rev Neurol, 140, 434
  7. Martinovic Z, 1983, Advances in epileptology, XIVth epilepsy international symposium, 301
  8. Posner E, Absence seizures in children, Clin Evid
  9. Rastogi P, 1991, Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy, J Assoc Physicians India, 39, 606
  10. 10.1111/j.1528-1157.1981.tb04330.x · doi:10.1111/j.1528-1157.1981.tb04330.x
  11. Sobaniec W, 2005, A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children, Pharmacol Rep, 57, 646
  12. 10.1001/archneurpsyc.1940.02280010078005 · doi:10.1001/archneurpsyc.1940.02280010078005
  13. 10.1016/S0920-1211(96)00074-5 · doi:10.1016/s0920-1211(96)00074-5
  14. 10.1177/088307389601100611 · doi:10.1177/088307389601100611

Cited by

See all 721

Metadata

Authors
Glauser, T., Ben‐Menachem, E., Bourgeois, B., Cnaan, A., Guerreiro, C., Kälviäinen, R., Mattson, R., French, J. A., Perucca, E., Tomson, T., & Guidelines, F. T. I. S. O. A.
Venue
Epilepsia
Publisher
Wiley
Published
2013-01-25
Volume
54
Issue
3
Pages
551-563
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2143243043
Cited by
721
References
65
FWCI
38.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.